TLR1/2 activation during heterologous prime-boost vaccination (DNA-MVA) enhances CD8+ T Cell responses providing protection against Leishmania (Viannia).

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples